Is Smith and Nephew a good stock?
There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Smith & Nephew stock. View analyst ratings for Smith & Nephew or view top-rated stocks.
Is Smith and Nephew publicly traded?
Smith+Nephew was incorporated and listed on the London Stock Exchange in 1937 and in 1999 the Group was also listed on the New York Stock Exchange. Today, Smith+Nephew is a public limited company incorporated and headquartered in the UK and doing business in many countries around the world.
Is Smith Nephew a buy?
Smith & Nephew has received a consensus rating of Buy. The company’s average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.
Who owns Smith Nephew?
Smith & Nephew
| Founder | Thomas James Smith |
| Headquarters | Watford, England, UK |
| Key people | Roberto Quarta (Chairman) Roland Diggelmann (CEO) |
| Products | Medical equipment |
| Revenue | $4,560 million (2020) |
How much do Smith and Nephew reps make?
Average Smith & Nephew Sales Representative yearly pay in the United States is approximately $60,862, which meets the national average.
Who is the CEO of Smith and Nephew?
Roland Diggelmann
Smith & Nephew/CEO
Is Smith Nephew a good company to work for?
On average, employees at Smith & Nephew give their company a 3.9 rating out of 5.0 – which is equal to the average rating for all companies on CareerBliss. The happiest Smith & Nephew employees are Sales Representatives submitting an average rating of 0.0.
What is the stock price of Smith and nephew?
Smith & Nephew Plc Ord Usd0.20 is listed on the London Stock Exchange, trading with ticker code SN.. It has a market capitalisation of £13,231 m, with approximately 879 m shares in issue. Over the last year, Smith & Nephew share price has been traded in a range of 364.5, hitting a high of 1681.5, and a low of 1317.
What does Smith and nephew snats stand for?
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces a new study showing that computer-guided technology for total hip arthroplasty (THA) – such as Smith+Nephew’s RI.HIP NAVIGATION – significantly reduces the risk of revision and increases patient satisfaction when using Smith+Nephew implants.
Who are premium members of London South East?
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here. London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.